Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine

NCT02823899 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

840

Enrollment

OTHER

Sponsor class

Conditions

Cholera

Interventions

BIOLOGICAL: HL-OCV
BIOLOGICAL: Shanchol

Sponsor

International Centre for Diarrhoeal Disease Research, Bangladesh

Collaborators

[object Object]